NL-OMON50899招募中3 期
SeMaglutide and Albuminuria Reduction Trial in obese individuals without diabetes - SMART
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age >= 18 years
- •Body Mass index >= 27 kg/m2
- •Albuminuria >= 30 mg/g and <= 3500 mg/g
- •eGFR >= 25 ml/min/1.73m2
- •Stable renal function prior to entry into the study defined as no more than
- •30% eGFR change in
- •3 months prior to enrolment
- •Signed Informed Consent
排除标准
- •Diagnosis with type 1 or type 2 Diabetes
- •Hba1c >= 6.5% at screening
- •Cardiovascular disease event in 3 months prior to enrollment
- •Treatment with GLP-1 RA < 4 weeks prior to screening
- •Uncontrolled thyroid disease TSH>6.0 mIU/L or <0.4 mIU/L at screening
- •Acute pancreatitis < 180 days prior to screening
- •History or presence of chronic pancreatitis
- •Females of child-bearing potential who are pregnant, breast-feeding or have
- •intention of
- •becoming pregnant or are not using adequate contraceptive measures
研究者
相似试验
进行中（未招募）
1 期
Trial to study the effect of semaglutide on reducing urinary albumin excretion in people with serious overweight without diabetes.EUCTR2021-001247-27-NLniversity Medical Center Groningen98
进行中（未招募）
1 期
Trial to study the effect of semaglutide on reducing urinary albumin excretion in people with serious overweight without diabetes.Overweight and obese individuals at high risk of chronic kidney disease progression.MedDRA version: 20.0Level: PTClassification code 10029883Term: ObesitySystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: PTClassification code 10001580Term: AlbuminuriaSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2021-001247-27-DEniversity Medical Center Groningen98
已完成
3 期
SeMaglutide and Albuminuria Reduction Trial in Obese Individuals Without DiabetesAlbuminuriaObesityNCT04889183University Medical Center Groningen125
尚未招募
4 期
Comparing Medications for Reducing Kidney Damage in Diabetes: A Study on Dapagliflozin Alone and with EplerenoneCTRI/2024/01/061952Dr Nikhil Kumar
进行中（未招募）
1 期
Feasibility of aggressively lowering urine albumin in individuals with kidney biopsy-proven diabetic kidney disease - A Pilot StudyDiabetic Kidney DiseaseMedDRA version: 21.1Level: LLTClassification code 10012687Term: Diabetic renal diseaseSystem Organ Class: 100000004857EUCTR2021-001661-21-DKHerlev and Gentofte Hospital20